Header Logo

Connection

James Mulshine to Cyclin-Dependent Kinase Inhibitor p16

This is a "connection" page, showing publications James Mulshine has written about Cyclin-Dependent Kinase Inhibitor p16.
  1. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst. 1995 May 17; 87(10):756-61.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.